|
Dec 13
|
IBD 50 Stocks To Watch: Biotech Leader Intra-Cellular Therapies Is Breaking Out Past A New Buy Point
|
|
Dec 8
|
Why Is Biogen Inc. (BIIB) Up 6.4% Since Last Earnings Report?
|
|
Dec 5
|
Intra-Cellular Therapies Highlights Data Presentations at the American College of Neuropsychopharmacology Annual Meeting
|
|
Nov 7
|
Wall Street Analysts Believe Intra-Cellular (ITCI) Could Rally 41.19%: Here's is How to Trade
|
|
Nov 6
|
We Think Intra-Cellular Therapies (NASDAQ:ITCI) Can Easily Afford To Drive Business Growth
|
|
Nov 3
|
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2023 Earnings Call Transcript
|
|
Nov 2
|
Intra-Cellular Therapies Inc (ITCI) Reports Q3 2023 Earnings, Raises Sales Guidance
|
|
Nov 2
|
Intra-Cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance
|
|
Aug 4
|
Intra-Cellular (ITCI) Q2 Earnings & Sales Top, '23 View Raised
|
|
Aug 4
|
Intra-Cellular Therapies to Present at the Canaccord Genuity 43rd Annual Growth Conference
|
|
Apr 27
|
Intra-Cellular Therapies (ITCI) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Apr 26
|
Intra-Cellular Therapies to Host First Quarter 2023 Financial Results Conference Call and Webcast
|